Trial of CPX-351 in Newly Diagnosed Elderly AML Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey E Lancet, MD
H. Lee Moffitt Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bc Cancer Research Center
Vancouver, British Columbia, Canada
- Queen Elisabeth Ii Health Sciences Center
Halifax, Nova Scotia, Canada
- Mcgill University Department of Oncology
Montreal, Quebec, Canada
- Arizona Cancer Center
Tucson, Arizona, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Uc Davis Cancer Center
Sacramento, California, United States
- University of California Medical Center
San Francisco, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Shands Jacksonville Medical Center
Jacksonville, Florida, United States
- H Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Blood and Marrow Transplant Group of Georgia
Atlanta, Georgia, United States
- Robert H.Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- St.Francis Hospital
Beech Grove, Indiana, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Northern New Jersey Cancer Associates
Hackensack, New Jersey, United States
- North Shore University Hospital
Manhasset, New York, United States
- Weil Cornell Medical Center
New York, New York, United States
- New York Medical College, Division of Oncology
Valhalla, New York, United States
- Blumenthal Cancer Center/mecklenburg Medical Group
Charlotte, North Carolina, United States
- Jewish Hospital
Cincinnati, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- University of Pittsburg Cancer Center
Pittsburgh, Pennsylvania, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Joe Arrington Cancer Center
Lubbock, Texas, United States
- Texas Tech University Health Sciences Center
Lubbock, Texas, United States
- Cancer Therapy and Research Center at the University of Texas
San Antonio, Texas, United States
- Froedlert Hospital/medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2008
- Primary completion
- 30 Jun 2010
- Completion
- 31 Dec 2011
- Last update posted
- 12 Jan 2018
- Registered enrollment
- 126
- Registry id
- NCT00788892
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.